Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension

Hypertension

Volumn 68, Issue 6, 2016, Pages 1415-1423

  Banek, Christopher T ^a   Knuepfer, Mark M ^b   Foss, Jason D ^a   Fiege, Jessica K ^a   Asirvatham Jeyaraj, Ninitha ^a   Van Helden, Dusty ^a   Shimizu, Yoji ^a   Osborn, John W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

afferent neurons; arterial pressure; denervation; deoxycorticosterone acetate; hypertension; inflammation

Indexed keywords

CXCL1 CHEMOKINE; DEOXYCORTICOSTERONE ACETATE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; EFFERENT NERVE; HEART RATE; HYPERTENSION; KIDNEY DENERVATION; KIDNEY NERVE; KIDNEY PARENCHYMA; LYMPHOCYTIC INFILTRATION; MALE; MEAN ARTERIAL PRESSURE; NEPHRITIS; NERVE CONDUCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SENSORY NERVE; SYMPATHETIC NERVE; T LYMPHOCYTE ACTIVATION; TELEMETRY; ADRENERGIC SYSTEM; ANIMAL; CHEMICALLY INDUCED; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; INNERVATION; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; REST; ROLE PLAYING; SENSORY NERVE CELL; SPRAGUE DAWLEY RAT; SYMPATHECTOMY;

ANIMALS; DESOXYCORTICOSTERONE ACETATE; DISEASE MODELS, ANIMAL; HYPERTENSION; KIDNEY; MALE; NEPHRITIS; NEURONS, AFFERENT; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REST; ROLE; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84994817754     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07850     Document Type: Article

References (44)

1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-e360.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223. doi: 10.1016/S0140-6736(05)17741-1.
3. Davis MI, Filion KB, Zhang D, Eisenberg MJ, Afilalo J, Schiffrin EL, Joyal D. Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62:231-241. doi: 10.1016/j.jacc.2013.04.010.
4. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol. 2010;298:R245-R253. doi: 10.1152/ajpregu.00647.2009.
5. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-1281. doi: 10.1016/S0140-6736(09)60566-3.
6. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity htn-2 trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
7. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393-1401. doi: 10.1056/NEJMoa1402670.
8. Desch S, Okon T, Heinemann D, Kulle K, Röhnert K, Sonnabend M, Petzold M, Müller U, Schuler G, Eitel I, Thiele H, Lurz P. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertension. 2015;65:1202-1208. doi: 10.1161/HYPERTENSIONAHA.115.05283.
9. Jacob F, Clark LA, Guzman PA, Osborn JW. Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approach. Am J Physiol Heart Circ Physiol. 2005;289:H1519-H1529. doi: 10.1152/ajpheart.00206.2005.
10. Ye S, Gamburd M, Mozayeni P, Koss M, Campese VM. A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens. 1998;11(6 pt 1):723-728.
11. Janssen BJ, Debets JJ, Struyker-Boudier HA, Smits JF. Role of sensory renal nerves in the development of spontaneous hypertension in rats. Clin Exp Hypertens A. 1987;9 Suppl 1:227-239.
12. Wyss JM, Aboukarsh N, Oparil S. Sensory denervation of the kidney attenuates renovascular hypertension in the rat. Am J Physiol. 1986;250(1 pt 2):H82-H86.
13. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25(4 pt 2):878-882.
14. Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension. Hypertension. 2014;64:118-124. doi: 10.1161/HYPERTENSIONAHA.113.03098.
15. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011;123:1940-1946. doi: 10.1161/CIRCULATIONAHA.110.991869.
16. Pokushalov E, Romanov A, Katritsis DG, Artyomenko S, Bayramova S, Losik D, Baranova V, Karaskov A, Steinberg JS. Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience. Heart Rhythm. 2014;11:1131-1138. doi: 10.1016/j.hrthm.2014.03.055.
17. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, Shirokova N, Karaskov A, Mittal S, Steinberg JS. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163-1170. doi: 10.1016/j.jacc.2012.05.036.
18. Kario K, Ikemoto T, Kuwabara M, Ishiyama H, Saito K, Hoshide S. Catheter-based renal denervation reduces hypoxia-triggered nocturnal blood pressure peak in obstructive sleep apnea syndrome. J Clin Hypertens (Greenwich). 2016;18:707-709. doi: 10.1111/jch.12759.
19. Witkowski A, Kadziela J. Obstructive sleep apnoea, resistant hypertension and renal denervation. EuroIntervention. 2013;9 (suppl R):R105-R109. doi: 10.4244/EIJV9SRA18.
20. Foss JD, Wainford RD, Engeland WC, Fink GD, Osborn JW. A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin. Am J Physiol Regul Integr Comp Physiol. 2015;308:R112-R122. doi: 10.1152/ajpregu.00427.2014.
21. Xiao L, Kirabo A, Wu J, Saleh MA, Zhu L, Wang F, Takahashi T, Loperena R, Foss JD, Mernaugh RL, Chen W, Roberts J 2nd, Osborn JW, Itani HA, Harrison DG. Renal denervation prevents immune cell activation and renal inflammation in angiotensin ii-induced hypertension. Circ Res. 2015;117:547-557. doi: 10.1161/CIRCRESAHA.115.306010.
22. Veelken R, Vogel EM, Hilgers K, Amann K, Hartner A, Sass G, Neuhuber W, Tiegs G. Autonomic renal denervation ameliorates experimental glomerulonephritis. J Am Soc Nephrol. 2008;19:1371-1378. doi: 10.1681/ASN.2007050552.
23. Miller RJ, Jung H, Bhangoo SK, White FA. Cytokine and chemokine regulation of sensory neuron function. Handbook of Experimental Pharmacology. 2009:417-449.
24. Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45:27-37. doi: 10.1097/AIA.0b013e318034194e.
25. Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003;63:1791-1800. doi: 10.1046/j.1523-1755.2003.00929.x.
26. Iyer A, Chan V, Brown L. The DOCA-salt hypertensive rat as a model of cardiovascular oxidative and inflammatory stress. Curr Cardiol Rev. 2010;6:291-297. doi: 10.2174/157340310793566109.
27. Burke SL, Lim K, Moretti JL, Head GA. Comparison of sympathetic nerve activity normalization procedures in conscious rabbits. Am J Physiol Heart Circ Physiol. 2016;310:H1222-H1232. doi: 10.1152/ajpheart.00866.2015.
28. Foss JD, Fink GD, Osborn JW. Differential role of afferent and efferent renal nerves in the maintenance of early-and late-phase Dahl S hypertension. Am J Physiol Regul Integr Comp Physiol. 2016;310:R262-R267. doi: 10.1152/ajpregu.00408.2015.
29. Moss NG, Scoltock AB. Age-dependent changes in afferent renal nerve activity in genetically hypertensive rats. Am J Physiol. 1992;262(5 pt 2):R834-R841.
30. Kopp UC, Cicha MZ, Smith LA. Dietary sodium loading increases arterial pressure in afferent renal-denervated rats. Hypertension. 2003;42:968-973. doi: 10.1161/01.HYP.0000097549.70134.D8.
31. Kottke FJ, Kubicek WG, Visscher MB. The production of arterial hypertension by chronic renal artery-nerve stimulation. Am J Physiol. 1945;145:38-47.
32. Patel KP, Knuepfer MM. Effect of afferent renal nerve stimulation on blood pressure, heart rate and noradrenergic activity in conscious rats. J Auton Nerv Syst. 1986;17:121-130.
33. Simon JK, Kasting NW, Ciriello J. Afferent renal nerve effects on plasma vasopressin and oxytocin in conscious rats. Am J Physiol. 1989;256(6 pt 2):R1240-R1244.
34. Xu B, Zheng H, Liu X, Patel KP. Activation of afferent renal nerves modulates RVLM-projecting PVN neurons. Am J Physiol Heart Circ Physiol. 2015;308:H1103-H1111. doi: 10.1152/ajpheart.00862.2014.
35. Ciriello J. Contribution of forebrain mechanisms in the maintenance of deoxycorticosterone acetate-salt hypertension. Clin Exp Hypertens A. 1988;10 Suppl 1:169-178.
36. Bealer SL. Hypothalamic knife cuts attenuate maintenance of deoxycorticosterone acetate-salt induced hypertension. Brain Res. 1984;309:192-195.
37. Castro AL, Almeida EF, Vadenal R, Lopes OU. Effects of anterior hypothalamic disconnection on the evolution of Goldblatt renal hypertension. A dual response. Hypertension. 1983;5(6 pt 3):V85-V89.
38. Marson O, Saragoça MA, Ribeiro AB, Bossolan D, Tufik S, Ramos OL. Anteroventral third ventricle and renin-angiotensin system interaction in the two-kidney, one clip hypertensive rat. Hypertension. 1983;5(6 pt 3):V90-V93.
39. Crofton JT, Share L, Shade RE, Lee-Kwon WJ, Manning M, Sawyer WH. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension. 1979;1:31-38.
40. Katholi RE, Naftilan AJ, Oparil S. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat. Hypertension. 1980;2:266-273.
41. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26:137-143.
42. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52:595-638.
43. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399-403.
44. Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R, Hilgers KF. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. Nephrol Dial Transplant. 2008;23:3456-3463. doi: 10.1093/ndt/gfn301.